Navigation Links
Rib-X Pharmaceuticals Antibiotic Drug Discovery Platform Discovers Novel Compounds with Activity Against Key Multiple Drug Resistant Gram-negative Bacteria
Date:8/31/2009

that are active against Gram-negative bacteria. This program exploits the peptidyl transferase region of the 50S subunit, which is the catalytic region of the ribosome and the binding site of many chemically distinct classes of antibiotics, including oxazolidinones (e.g., linezolid), lincosamides (e.g., clindamycin), phenyl propanoids (e.g., chloramphenicol), pleuromutilins (e.g., retapamulin), macrolides/ketolides (e.g., azithromycin) and sparsomycin. Rib-X has created five completely novel series of compounds targeting two novel sites that show good antibacterial activity against a number of clinically important multi drug resistant Gram-negative pathogens.

About Rib-X Pharmaceuticals, Inc.

Rib-X Pharmaceuticals, Inc. is a product-driven small molecule drug discovery and development company focused on the structure-based design of new classes of antibiotics. The Company's underlying drug discovery engine capitalizes on its proprietary high-resolution crystal structure of the ribosome, which performs an essential role in protein synthesis. Many known, commercially valuable antibiotics exert their effects by binding to the bacterial ribosome. The Company's integrated research strategy, which combines state-of-the-art, proprietary computational analysis, X-ray crystallography, medicinal chemistry, microbiology and biochemistry, allows it to rapidly synthesize new agents designed to avoid typical antibiotic resistance mechanisms. Rib-X's iterative intelligent engine has yielded several distinctive new antibiotics that can be used for the treatment of either community- or hospital-acquired infections. In addition to Rx-04, Rib-X has successfully completed Phase 2 trials with delafloxacin (RX-3341), a broad spectrum fluoroquinolone with potent activity against quinolone resistant Gram-positive bacteria including MRSA. Radezolid (RX-1741), an oxazolidinone that was discovered at Rib-X, as an oral/IV agent for treatment of ser
'/>"/>

SOURCE Rib-X Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Rib-X Pharmaceuticals Initiates Two Phase 2 Studies for Novel Antibiotic Compound RX-1741
2. Rib-X Pharmaceuticals to Present at Cambridge Healthtech Institutes 2nd Annual Challenge of Antibacterial Development Conference
3. Rib-X Pharmaceuticals, Inc. Announces Formation of Clinical Advisory Board
4. Rib-X Pharmaceuticals to Present at the 2008 ICAAC/IDSA Joint Meeting
5. Rib-X Pharmaceuticals Announces Positive Phase 2 Study Results for Delafloxacin and a $25 Million Financing
6. Rib-X Pharmaceuticals Announces Presentations at the 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
7. Rib-X Pharmaceuticals, Inc. Appoints Dr. Russell Greig to Board of Directors
8. Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Radezolid in Community-Acquired Pneumonia
9. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
10. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
11. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... 26 August 2014 - A team of engineers ... ZigBee wireless sensor network (WSN) for satellite communications. ... major constraint in satellite design, constructing a lightweight, ... with cabling inside the satellite has always been ... team at the Satellite Research Centre of Nanyang ...
(Date:8/26/2014)... Aug. 26, 2014  ViveBio, LLC a leading ... stabilization and transportation, announced today that it has ... LLC (LPS) of Knoxville, Tennessee ... the United States . ViveST ... ambient temperature dried biological specimen transport systems.  The ...
(Date:8/26/2014)... Vycom announced today that Modutek ... chemical process equipment, has selected its Flametec materials for ... Rare Isotope Beams (FRIB). This involved the creation ... with Vycom’s Flametec PVC-C and Kytec PVDF material to ... of FRIB’s linear accelerator (known as LINAC). ...
(Date:8/26/2014)... CITY, Calif. , Aug. 26, 2014 /PRNewswire/ ... development and commercialization of oncology diagnostic products, has ... as a 2015 Technology Pioneer . As ... is one of 24 companies across a wide ... prestigious accolade. Guardant360 ® , ...
Breaking Biology Technology:ZigBee in the Sky 2ViveBio and Laboratory Procurement Services Sign Agreement for Distribution of the ViveST Line of Products 2Modutek Selects Vycom’s Flametec Materials for Michigan State University’s Superconductor Equipment 2Modutek Selects Vycom’s Flametec Materials for Michigan State University’s Superconductor Equipment 3Guardant Health Named a 2015 Technology Pioneer by World Economic Forum 2
... specialists has completed their first successful content migrations to the ... global chemical manufacturing company and a multinational biotechnology company. ... ... 2008 -- Impact Systems Inc., ( www.impactinfosys.com ), a leading ...
... Duska Therapeutics,Inc. (OTC Bulletin Board: DSKA.OB) ("Duska" ... is available via Standard & Poor,s,Corporation Records Listing ... of Duska Therapeutics is published in the Daily ... manual for secondary,trading in approximately 38 states under ...
... 26 ValGenesis, Inc., a leading,provider of ... availability of ValGenesis 2.0, the latest version ... cycle,management and automation product., Life science ... manage the entire validation life cycle and ...
Cached Biology Technology:Impact Systems Announces Completion of Successful Enterprise Content Migrations to Documentum 6 2Impact Systems Announces Completion of Successful Enterprise Content Migrations to Documentum 6 3Duska Therapeutics Obtains Standard & Poor's Listing 2ValGenesis, Inc. Announces Worldwide Release of Validation Life Cycle Management System - ValGenesis 2.0 2ValGenesis, Inc. Announces Worldwide Release of Validation Life Cycle Management System - ValGenesis 2.0 3
(Date:8/25/2014)... willpower to avoid becoming obese or to slim ... of minority groups, maintaining a healthy weight can be ... Luis Rivera, an experimental social psychologist at Rutgers University-Newark. ... the United States to endure negative stereotypes, pervasive messages ... attitudes can prevent people from doing what is needed ...
(Date:8/25/2014)... 1 in 6 adults worldwide may suffer from ... cause serious complications. Auriculotherapy, a form of acupuncture ... ear, may help in managing constipation. Evidence from ... the effectiveness of auriculotherapy in treating patients with ... article in The Journal of Alternative and ...
(Date:8/25/2014)... with the completion of a new study. , Scientists ... cells in a living animal for the first time. ... organ next to the heart that produces immune cells ... against disease. , They hope that, with further research, ... with a weakened immune system. , The team ...
Breaking Biology News(10 mins):Racial and ethnic stereotypes may contribute to obesity among minorities 2Scientists first to grow organ in animal from cells created in lab 2
... mutation that causes X-linked mental retardation for which there ... article to be published electronically on Tuesday, March 20, ... , Investigators F. Lucy Raymond (Cambridge Institute of Medical ... Tarpey (Wellcome Trust Sanger Institute, Hixton, UK) describe the ...
... of California, San Diego and the University of Bonn ... plant species richness. Covering several hundred thousand species, the ... map of the distribution of biodiversity on Earth to ... in this week's early online issue of the journal ...
... HIV-infected patients in Uganda who self-paid for their antiretroviral ... financial demands or supply logistical disruptions. These treatment ... medications in patients. , These findings by a team ... Makerere University, Kampala, and UCSF are reported in the ...
Cached Biology News:Severe mental retardation gene mutation identified 2Biologists produce global map of plant biodiversity 2Resistance to anti-HIV drugs in Uganda developed due to drug supply problems 2
... The new D-LUX Detection Platform ... to provide the most sensitive, specific, ... qPCR. Invitrogens D-LUX Detection Platform offers ... equal to TaqMan probes, high signal/background ...
...
Request Info...
... Blood is aseptically collected via cardiac puncture ... Zealand White, mixed sex). It is then centrifuged ... pooled, sterile filtered and bottled at 4C then ... IF YOU HAVE ALWAYS USED PEL-FREEZ COMPLEMENT, YOU ...
Biology Products: